Genmab A/S Statistics Share Statistics Genmab A/S has 615.07M
shares outstanding. The number of shares has increased by -2.56%
in one year.
Shares Outstanding 615.07M Shares Change (YoY) -2.56% Shares Change (QoQ) -2.8% Owned by Institutions (%) 99.99% Shares Floating 648.63M Failed to Deliver (FTD) Shares 134 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 3.66M, so 0.59% of the outstanding
shares have been sold short.
Short Interest 3.66M Short % of Shares Out 0.59% Short % of Float 0.6% Short Ratio (days to cover) 3.03
Valuation Ratios The PE ratio is 12.39 and the forward
PE ratio is 1.61.
Genmab A/S's PEG ratio is
0.15.
PE Ratio 12.39 Forward PE 1.61 PS Ratio 4.51 Forward PS 0.5 PB Ratio 2.65 P/FCF Ratio 12.81 PEG Ratio 0.15
Financial Ratio History Enterprise Valuation Genmab A/S has an Enterprise Value (EV) of 887.01M.
EV / Sales 0.04 EV / EBITDA 0.09 EV / EBIT 0.11 EV / FCF 0.12
Financial Position The company has a current ratio of 5.25,
with a Debt / Equity ratio of 0.03.
Current Ratio 5.25 Quick Ratio 5.24 Debt / Equity 0.03 Debt / EBITDA 0.11 Debt / FCF 0.14 Interest Coverage 55.86
Financial Efficiency Return on Equity is 21.38% and Return on Invested Capital is 14.13%.
Return on Equity 21.38% Return on Assets 17.12% Return on Invested Capital 14.13% Revenue Per Employee $8.16M Profits Per Employee $2.97M Employee Count 2,638 Asset Turnover 0.47 Inventory Turnover 15.89
Taxes Income Tax 1.32B Effective Tax Rate 14.4%
Stock Price Statistics The stock price has increased by -20.48% in the
last 52 weeks. The beta is 0.8, so Genmab A/S's
price volatility has been higher than the market average.
Beta 0.8 52-Week Price Change -20.48% 50-Day Moving Average 21.74 200-Day Moving Average 21.1 Relative Strength Index (RSI) 46.02 Average Volume (20 Days) 1,351,996
Income Statement In the last 12 months, Genmab A/S had revenue of 21.53B
and earned 7.84B
in profits. Earnings per share was 12.14.
Revenue 21.53B Gross Profit 20.54B Operating Income 6.7B Net Income 7.84B EBITDA 9.7B EBIT 9.28B Earnings Per Share (EPS) 12.14
Full Income Statement Balance Sheet The company has 9.86B in cash and 1.03B in
debt, giving a net cash position of 8.83B.
Cash & Cash Equivalents 9.86B Total Debt 1.03B Net Cash 8.83B Retained Earnings 23.55B Total Assets 6.59B Working Capital 3.28B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 7.77B
and capital expenditures -187M, giving a free cash flow of 7.58B.
Operating Cash Flow 7.77B Capital Expenditures -187M Free Cash Flow 7.58B FCF Per Share 11.73
Full Cash Flow Statement Margins Gross margin is 95.42%, with operating and profit margins of 31.14% and 36.44%.
Gross Margin 95.42% Operating Margin 31.14% Pretax Margin 42.57% Profit Margin 36.44% EBITDA Margin 45.05% EBIT Margin 31.14% FCF Margin 35.23%
Dividends & Yields GMAB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 8.07% FCF Yield 78.06%
Dividend Details Analyst Forecast The average price target for GMAB is $37,
which is 75.5% higher than the current price. The consensus rating is "Buy".
Price Target $37 Price Target Difference 75.5% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $130.02 Lynch Upside 516.79% Graham Number 1245.13 Graham Upside 5806.69%
Stock Splits The last stock split was on May 1, 2018. It was a
forward
split with a ratio of 5:1.
Last Split Date May 1, 2018 Split Type forward Split Ratio 5:1
Scores Altman Z-Score 14.4 Piotroski F-Score 5
